Photocleavable peptide-conjugated magnetic beads for protein kinase assays by MALDI-TOF MS

Bioconjugate Chemistry

Volumn 21, Issue 10, 2010, Pages 1917-1924

  Zhou, Guangchang ^a   Yan, Xiaoliang ^a   Wu, Ding ^a   Kron, Stephen J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ADENOSINE TRIPHOSPHATE; BCR ABL PROTEIN; DASATINIB; IMATINIB; MACROGOL DERIVATIVE; RECOMBINANT ENZYME;

ARTICLE; CHRONIC MYELOID LEUKEMIA; ENZYME INHIBITION; IC 50; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN IMMOBILIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

EID: 77958165596     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc1003058     Document Type: Article

References (65)

1. Lu, Z. M. and Hunter, T. (2009) Degradation of activated protein kinases by ubiquitination Annu. Rev. Biochem. 78, 435-475
2. Hunter, T. (2000) Signaling-2000 and beyond Cell 100, 113-127
3. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human genome Science 298, 1912-1934
4. Noble, M. E. M., Endicott, J. A., and Johnson, L. N. (2004) Protein kinase inhibitors: insights into drug design from structure Science 303, 1800-1805
5. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., and Mustelin, T. (2004) Protein tyrosine phosphatases in the human genome Cell 117, 699-711 (Pubitemid 38748887)
6. Cohen, P. (2002) Protein kinases-the major drug targets of the twenty-first century? Nat. Rev. Drug Discovery 1, 309-315
7. Swanson, C. D., Paniagua, R. T., Lindstrom, T. M., and Robinson, W. H. (2009) Tyrosine kinases as targets for the treatment of rheumatoid arthritis Nat. Rev. Rheumatol. 5, 317-324
8. Zhang, J. M., Yang, P. L., and Gray, N. S. (2009) Targeting cancer with small molecule kinase inhibitors Nat. Rev. Cancer 9, 28-39
9. Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., and Lydon, N. B. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat. Med. 2, 561-566
10. Grant, S. (2009) Therapeutic protein kinase inhibitors Cell. Mol. Life Sci. 66, 1163-1177
11. Johnson, L. N. (2009) Protein kinase inhibitors: contributions from structure to clinical compounds Q. Rev. Biophys. 42, 1-40
12. Sebolt-Leopold, J. S. and English, J. M. (2006) Mechanisms of drug inhibition of signalling molecules Nature 441, 457-462
13. Houseman, B. T., Huh, J. H., Kron, S. J., and Mrksich, M. (2002) Peptide chips for the quantitative evaluation of protein kinase activity Nat. Biotechnol. 20, 270-274
14. Rathore, R., Corr, J., Scott, G., Vollmerhaus, P., and Greis, K. D. (2008) Development of an inhibitor screening platform via mass spectrometry J. Biomol. Screen 13, 1007-1013
15. Kondo, N. and Nishimura, S. I. (2009) MALDI-TOF mass-spectrometry-based versatile method for the characterization of protein kinases Chem.-Eur. J. 15, 1413-1421
16. von Ahsen, O. and Bomer, U. (2005) High-throughput screening for kinase inhibitors ChemBioChem 6, 481-490
17. Shults, M. D., Janes, K. A., Lauffenburger, D. A., and Imperiali, B. (2005) A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates Nat. Methods 2, 277-283
18. Zondlo, S. C., Gao, F., and Zondlo, N. J. (2010) Design of an encodable tyrosine kinase-inducible domain: detection of tyrosine kinase activity by terbium luminescence J. Am. Chem. Soc. 132, 5619-5621
19. Placzek, E. A., Plebanek, M. P., Lipchik, A. M., Kidd, S. R., and Parker, L. L. (2010) A peptide biosensor for detecting intracellular Abl kinase activity using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Anal. Biochem. 397, 73-78
20. Wu, D., Sylvester, J. E., Parker, L. L., Zhou, G., and Kron, S. J. (2010) Peptide reporters of kinase activity in whole cell lysates Biopolym. (Pept. Sci.) 94, 475-486
21. Mand, M. R., Wu, D., Veach, D. R., and Kron, S. J. (2010) Cell treatment and lysis in 96-well filter-bottom plates for screening Bcr-Abl activity and inhibition in whole-cell extracts J. Biomol. Screen 15, 434-440
22. Sylvester, J. E. and Kron, S. J. (2010) A bead-based activity screen for small-molecule inhibitors of signal transduction in chronic myelogenous leukemia cells Mol. Cancer Ther. 9, 1469-1481
23. Kim, M., Shin, D.-S., Kim, J., and Yoon-Sik Lee, Y.-S. (2010) Substrate screening of protein kinases: Detection methods and combinatorial peptide libraries Pept. Sci. DOI: 10.1002/bip.21506.
24. Reineke, U., Volkmer-Engert, R., and Schneider-Mergener, J. (2001) Applications of peptide arrays prepared by the SPOT-technology Curr. Opin. Biotechnol. 12, 59-64 (Pubitemid 32843145)
25. Fodor, S. P. A., Read, J. L., Pirrung, M. C., Stryer, L., Lu, A. T., and Solas, D. (1991) Light-directed, spatially addressable parallel chemical synthesis Science 251, 767-773
26. MacBeath, G. and Schreiber, S. L. (2000) Printing proteins as microarrays for high-throughput function determination Science 289, 1760-1763
27. Lesaicherre, M. L., Uttamchandani, M., Chen, G. Y. J., and Yao, S. Q. (2002) Developing site-specific immobilization strategies of peptides in a microarray Bioorg. Med. Chem. Lett. 12, 2079-2083
28. Wu, D., Mand, M. R., Veach, D. R., Parker, L. L., Clarkson, B., and Kron, S. J. (2008) A solid-phase Bcr-Abl kinase assay in 96-well hydrogel plates Anal. Biochem. 375, 18-26
29. Uttamchandani, M. and Yao, S. Q. (2008) Peptide microarrays: Next generation biochips for detection, diagnostics and high-throughput screening Curr. Pharm. Des. 14, 2428-2438
30. Kohn, M. (2009) Immobilization strategies for small molecule, peptide and protein microarrays J. Pept. Sci. 15, 393-397
31. Ding, H., Prodinger, W. M., and Kopecek, J. (2006) Identification of CD21-binding peptides with phage display and investigation of binding properties of HPMA copolymer-peptide conjugates Bioconjugate Chem. 17, 514-523
32. Kim, Y. P., Oh, E., Oh, Y. H., Moon, D. W., Lee, T. G., and Kim, H. S. (2007) Protein kinase assay on peptide-conjugated gold nanoparticles by using secondary-ion mass spectrometric imaging Angew. Chem., Int. Ed. 46, 6816-6819
33. Inamori, K., Kyo, M., Matsukawa, K., Inoue, Y., Sonoda, T., Tatematsu, K., Tanizawa, K., Mori, T., and Katayama, Y. (2008) Optimal surface chemistry for peptide immobilization in on-chip phosphorylation analysis Anal. Chem. 80, 643-650
34. Ding, H., Prodinger, W. M., and Kopecek, J. (2006) Two-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugates Biomacromolecules 7, 3037-3046
35. Li, Y. J., Xie, W. H., and Fang, G. J. (2008) Fluorescence detection techniques for protein kinase assay Anal. Bioanal. Chem. 90, 2049-2057
36. Olive, D. M. (2004) Quantitative methods for the analysis of protein phosphorylation in drug development Expert Rev. Proteomics 1, 327-341
37. Ma, H. C., Deacon, S., and Horiuchi, K. (2008) The challenge of selecting protein kinase assays for lead discovery optimization Expert Opin. Drug Discovery 3, 607-621
38. McLachlin, D. T. and Chait, B. T. (2001) Analysis of phosphorylated proteins and peptides by mass spectrometry Curr. Opin. Chem. Biol. 5, 591-602
39. Reinders, J. and Sickmann, A. (2005) State-of-the-art in phosphoproteomics Proteomics 5, 4052-4061
40. Min, D. H., Tang, W. J., and Mrksich, M. (2004) Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor Nat. Biotechnol. 22, 717-723
41. Kostiainen, M. A., Smith, D. K., and Ikkala, O. (2007) Optically triggered release of DNA from multivalent dendrons by degrading and charge-switching multivalency Angew. Chem., Int. Ed. 46, 7600-7604
42. Yan, F. N., Chen, L. H., Tang, Q. L., and Rong, W. (2004) Synthesis and characterization of a photocleavable cross-linker and its application on tunable surface modification and protein photodelivery Bioconjugate Chem. 15, 1030-1036
43. Saran, D. and Burke, D. H. (2007) A versatile photocleavable bifunctional linker for facile synthesis of substrate-DNA conjugates for the selection of nucleic acid catalysts Bioconjugate Chem. 18, 275-279
44. Kloxin, A. M., Kasko, A. M., Salinas, C. N., and Anseth, K. S. (2009) Photodegradable hydrogels for dynamic tuning of physical and chemical properties Science 324, 59-63
45. Parker, L. L., Brueggemeier, S. B., Rhee, W. J., Wu, D., Kent, S. B. H., Kron, S. J., and Palecek, S. P. (2006) Photocleavable peptide hydrogel arrays for MALDI-TOF analysis of kinase activity Analyst 131, 1097-1104
46. Kinumi, T., Niki, E., Shigeri, Y., and Matsumoto, H. (2005) Affinity-tagged phosphorylation assay by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (ATPA-MALDI): Application to calcium/calmodulin-dependent protein kinase J. Biochem. 138, 791-796
47. Zhou, G., Sylvester, J. E., Wu, D., Veach, D. R., and Kron, S. J. ((2010)) A magnetic bead-based protein kinase assay with dual detection techniques. Anal. Biochem., doi:10.1016/j.ab.2010.08.034.
48. Parker, L., Engel-Hall, A., Drew, K., Steinhardt, G., Helseth, D. L., Jabon, D., McMurry, T., Angulo, D. S., and Kron, S. J. (2008) Investigating quantitation of phosphorylation using MALDI-TOF mass spectrometry J. Mass Spectrom. 43, 518-527
49. Annan, R. S. and Carr, S. A. (1996) Phosphopeptide analysis by matrix-assisted laser desorption time-of-flight mass spectrometry Anal. Chem. 68, 3413-3421
50. Rowley, J. D. (1973) New consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining Nature 243, 290-293
51. Nagar, B., Hantschel, O., Young, M. A., Scheffzek, K., Veach, D., Bornmann, V., Clarkson, B., Superti-Furga, G., and Kuriyan, J. (2003) Structural basis for the autoinhibition of c-Abl tyrosine kinase Cell 112, 859-871
52. Warmuth, M., Danhauser-Riedl, S., and Hallek, M. (1999) Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies Ann. Hematol. 78, 49-64
53. Cheung, C. L., Camarero, J. A., Woods, B. W., Lin, T. W., Johnson, J. E., and De Yoreo, J. J. (2003) Fabrication of assembled virus nanostructures on templates of chemoselective linkers formed by scanning probe nanolithography J. Am. Chem. Soc. 125, 6848-6849
54. Camarero, J. A., Kwon, Y., and Coleman, M. A. (2004) Chemoselective attachment of biologically active proteins to surfaces by expressed protein ligation and its application for "protein chip" fabrication J. Am. Chem. Soc. 126, 14730-14731
55. Niculescu-Duvaz, D., Getaz, J., and Springer, C. J. (2008) Long functionalized poly(ethylene glycol)s of defined molecular weight: Synthesis and application in solid-phase synthesis of conjugates Bioconjugate Chem. 19, 973-981
56. Wegner, G. J., Lee, H. J., and Corn, R. M. (2002) Characterization and optimization of peptide arrays for the study of epitope-antibody interactions using surface plasmon resonance imaging Anal. Chem. 74, 5161-5168
57. Jia, Y., Gu, X. J., Brinker, A., and Warmuth, M. (2008) Measuring the tyrosine kinase activity: a review of biochemical and cellular assay technologies Expert Opin. Drug Discovery 3, 959-978
58. Ficarro, S. B., Adelmant, G., Tomar, M. N., Zhang, Y., Cheng, V. J., and Marto, J. A. (2009) Magnetic bead processor for rapid evaluation and optimization of parameters for phosphopeptide enrichment Anal. Chem. 81, 4566-4575
59. Rusmini, F., Zhong, Z. Y., and Feijen, J. (2007) Protein immobilization strategies for protein biochips Biomacromolecules 8, 1775-1789
60. Brasher, B. B. and Van Etten, R. A. (2000) c-Ab1 has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines J. Biol. Chem. 275, 35631-35637
61. Radujkovic, A., Schad, M., Topaly, J., Veldwijk, M. R., Laufs, S., Schultheis, B. S., Jauch, A., Melo, J. V., Fruehauf, S., and Zeller, W. J. (2005) Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL-Inhibition of P-glycoprotein function by 17-AAG Leukemia 19, 1198-1206
62. De Keersmaecker, K., Versele, M., Cools, J., Superti-Furga, G., and Hantschel, O. (2008) Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases Leukemia 22, 2208-2216
63. Rix, U., Hantschel, O., Duernberger, G., Rix, L. L. R., Planyavsky, M., Fernbach, N. V., Kaupe, I., Bennett, K. L., Valent, P., Colinge, J., Kocher, T., and Superti-Furga, G. (2007) Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib, reveal novel kinase and nonkinase targets Blood 110, 4055-4063
64. Hantschel, O., Rix, U., Schmidt, U., Burckstummer, T., Kneidinger, M., Schutze, G., Colinge, J., Bennett, K. L., Ellmeier, W. R., Valent, P., and Superti-Furga, G. (2007) The Btk tyrosine kinase is a major target of the Bcr-Abi inhibitor dasatinib Proc. Natl. Acad. Sci. U.S.A. 104, 13283-13288
65. Okabe, S., Tauchi, T., and Ohyashiki, K. (2008) Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells Clin. Cancer Res. 14, 6181-6186